Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5270734
Max Phase: Preclinical
Molecular Formula: C58H60N6O6
Molecular Weight: 937.15
Associated Items:
ID: ALA5270734
Max Phase: Preclinical
Molecular Formula: C58H60N6O6
Molecular Weight: 937.15
Associated Items:
Canonical SMILES: Cc1cc(C(=O)N2C[C@@H](C(=O)N[C@H]3C[C@@H]3c3ccccc3)[C@H](C(=O)N[C@H]3C[C@@H]3c3ccccc3)C2)c(C)cc1C(=O)N1C[C@@H](C(=O)N[C@H]2C[C@@H]2c2ccccc2)[C@H](C(=O)N[C@H]2C[C@@H]2c2ccccc2)C1
Standard InChI: InChI=1S/C58H60N6O6/c1-33-23-40(58(70)64-31-47(55(67)61-51-27-43(51)37-19-11-5-12-20-37)48(32-64)56(68)62-52-28-44(52)38-21-13-6-14-22-38)34(2)24-39(33)57(69)63-29-45(53(65)59-49-25-41(49)35-15-7-3-8-16-35)46(30-63)54(66)60-50-26-42(50)36-17-9-4-10-18-36/h3-24,41-52H,25-32H2,1-2H3,(H,59,65)(H,60,66)(H,61,67)(H,62,68)/t41-,42-,43-,44-,45-,46-,47-,48-,49+,50+,51+,52+/m1/s1
Standard InChI Key: DKCQGOIOFIGLDX-XVLAHCRKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 937.15 | Molecular Weight (Monoisotopic): 936.4574 | AlogP: 6.37 | #Rotatable Bonds: 14 |
Polar Surface Area: 157.02 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.45 | CX LogD: 5.45 |
Aromatic Rings: 5 | Heavy Atoms: 70 | QED Weighted: 0.10 | Np Likeness Score: -0.34 |
1. Kaur A, Kaushik D, Piplani S, Mehta SK, Petrovsky N, Salunke DB.. (2021) TLR2 Agonistic Small Molecules: Detailed Structure-Activity Relationship, Applications, and Future Prospects., 64 (1.0): [PMID:33346636] [10.1021/acs.jmedchem.0c01627] |
Source(1):